Showing results (11-20 of 16) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
The Journal of Investigative Dermatology|June 14, 2021
Safety, Tolerability, and Activity of ALXN1830 Targeting the Neonatal Fc Receptor in Chronic PemphigusVictoria P Werth, Donna A Culton, Josef S S Concha, et al.Mbio|January 2, 2025
Are we serologically prepared against an avian influenza pandemic and could seasonal flu vaccines help us?Iván Sanz-Muñoz, Javier Sánchez-Martínez, Carla Rodríguez-Crespo, et al.The Journal of Investigative Dermatology|May 1, 2022
Safety and Efficacy of Lenabasum, a Cannabinoid Receptor Type 2 Agonist, in Patients with Dermatomyositis with Refractory Skin Disease: A Randomized Clinical TrialVictoria P Werth, Emily Hejazi, Sandra M Pena, et al.Arthritis Research & Therapy|January 5, 2022
Cannabinoid type 2 receptor (CB2R) distribution in dermatomyositis skin and peripheral blood mononuclear cells (PBMCs) and in vivo effects of LenabasumTMSpandana Maddukuri, Jay Patel, De Anna Diaz, et al.The British Journal of Dermatology|May 4, 2019
Developing classification criteria for skin-predominant dermatomyositis: the Delphi processJ S S Concha, S Pena, R G Gaffney, et al.The British Journal of Dermatology|July 24, 2018
Evaluation of the reliability and validity of the Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) in paediatric cutaneous lupus among paediatric dermatologists and rheumatologistsC J Kushner, M Tarazi, R G Gaffney, et al.Pageof 2